［1］Cronin JC，Loftus SK，Baxter LL.Identification and functional analysis of SOX10 phosphorylation sites in melanoma［J］.PLoS One，2018，13(1)：34.
［2］Chiu K，Ionescu DN，Hayes M.SOX10 expression in mammary invasive ductal carcinomas and benign breast tissue［J］.Virchows Arch，2019，09(11)：3642-3647.
［3］De la Rocha AMA，Sampron N，Alonso MM，et al.Role of SOX family of transcription factors in central nervous system tumors［J］.Am J Cancer Res，2014，4(4)：312-324.
［4］WU Wenda，WU Qianqian.Research progress of Sox gene in glioma［J］.Journal of clinical neurology，2016，29(04)：310-312.［伍文达，伍倩倩.Sox基因在神经胶质瘤中的研究进展［J］.临床神经病学杂志，2016，29(04)：310-312.］
［5］Tong X，Li L，Li X，et al.SOX10：A novel HMG-box-containing tumor suppressor，inhibits growth and metastasis of digestive cancers by suppressing the Wnt/beta-catenin pathway［J］.Oncotarget，2014，5(21)：10571-10583.
［6］Miettinen M，McCue PA，Sarlomo-Rikala M，et al.Sox10-a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue：A systematic analysis of 5134 tumors［J］.Am J Surg Pathol，2015，39(6)：826-835.
［7］CHENG Kai，WANG Hai，WANG Jiandong，et al.Progress of application of SOX10 in pathological diagnosis of tumor［J］.Journal of Diagnostic Pathology，2014，21(12)：780-783.［程凯，王海，王建东，等.SOX10在肿瘤病理诊断中的应用研究进展［J］.诊断病理学杂志，2014，21(12)：780-783.］
［8］Nonaka D，Chiriboga L，P Rubin B.Sox10：A Pan-schwannian and melanocytic marker［J］.American Journal of Surgical Pathlogy，2008：1291-1298.
［9］Boulagnon-Rombi C，Fleury C，Fichel C，et al.Immunohistochemical approach to the differential diagnosis of meningiomas and their mimics［J］.J Neuropathol Exp Neurol，2017，76(4)：289-298.
［10］Kordes U，Hagel C.Expression of SOX9 and SOX10 in central neuroepithelial tumor［J］.J Neurooncol，2006，80(2)：151-155.
［11］LI Haiying，ZHANG Hua，QIU Changqing，et al.Effects of SOX10 on proliferation and dedifferentiation of glioma cells［J］.Shandong Medicine，2012，52(16)：12-14，103.［李海英，张华，仇长青，等.SOX10对胶质瘤细胞增殖及去分化的影响［J］.山东医药，2012，52(16)：12-14，103.］
［12］Ersen A，Pekmezci M，Folpe AL，et al.Comparision of new diagnostic tools for malignant peripheral nerve sheath tumors［J］.Pathology & Oncology Research，2016，23(2)：393-398.
［13］Kang Y，Pekmezci M，Folpe AL，et al.Diagnostic utility of SOX10 to distinguish malignant peripheral nerve sheath tumor from synovial sarcoma，including intraneural synovial sarcoma［J］.Mod Pathol，2014，27(1)：55-61.
［14］Karamchandani J，Nielsen T，Van de Rijn M，et al.Sox10 and S100 in the diagnosis of soft-tissue neoplasms［J］.Appl Immunohistochem Mol Morphol，2012，20(5)：445-450.
［15］Cronin JC，Watkins-Chow DE，Incao A，et al.SOX10 ablation arrests cell cycle，induces senescence，and suppresses melanomagenesis［J］.Cancer Res，2013，73(18)：5709-5718.
［16］Hata JL，Correa H，Krishnan C，et al.Diagnostic utility of PHOX2B in primary and treated neuroblastoma and in neuroblastoma metastatic to the bone marrow［J］.Arch Pathol Lab Med，2015，139(4)：543-546.
［17］Kared H，Martelli S，Ng TP，et al.CD57 in human natural killer cells and T-lymphocytes［J］.Cancer Immunol Immunother，2016，65(4)：441-452.
［18］Ali TH，Pisanti S，Ciaglia E，et al.Enrichment of CD56(dim)KIR+ CD57+ highly cytotoxic NK cells in tumour-infiltrated lymph nodes of melanoma patients［J］.Nat Commun，2014，4(5)：5639.
［19］SHAN Ying，GAO Dan，LIU Yong，et al.Application of bone marrow cell morphology combined with cytochemical staining in the diagnosis of neuroblastoma［J］.Shandong Medicine，2016，56(17)：77-79.［单莹，高丹，刘勇，等.骨髓细胞形态学联合细胞化学染色检测在神经母细胞瘤诊断中的应用［J］.山东医药，2016，56(17)：77-79.］
［20］Farschtschi S，Park S-J，Sawitzki B，et al.Effector T cell subclasses associate with tumor burden in neurofibromatosis type 1 patients［J］.Cancer Immunology，Immunotherapy，2016，65(9)：1113-1121.
［21］Schlitter AM，Dorneburg C，Barth TF，et al.CD57(high) neuroblastoma cells have aggressive attributes ex situ and an undifferentiated phenotype in patients［J］.PLoS One，2012，7(8)：42025.
［22］WU Shanshan，FAN Yuwei，GAO Jing，et al.Clinical significance and progress of S100B protein in neurological diseases［J］.Advances in Modern Biomedicine，2015，15(16)：3197-3200.［吴珊珊，范宇威，高静，等.S100B蛋白在神经系统疾病中的临床意义及进展［J］.现代生物医学进展，2015，15(16)：3197-3200.］
［23］Rezaei O，Pakdaman H，Gharehgozli K，et al.S100 B：A new concept in neurocritical care［J］.Iranian Journal of Neurology，2017，16(2)：83-89.
［24］Tandon A.Endobronchial neurogenic tumor：A combination of traumatic neuroma and neurofibroma［J］.Respir Med Case Rep，2017，2(20)：154-155.
［25］Ma Y，Shen B，Jia Y，et al.Pancreatic schwannoma：A case report and an updated 40-year review of the literature yielding 68 cases［J］.BMC Cancer，2017，17(1)：853.
［26］Munoz-Gutiérrez JF，Garner MM，Kiupel M.Primary central nervous system neoplasms in African hedgehogs［J］.Journal of Veterinary Diagnostic Investigation，2018，30(5)：715-720.
［27］Spitzbarth I，Heinrich F，Herder V，et al.Canine central nervous system neoplasm phenotyping using tissue microarray technique［J］.Vet Pathol，2017，54(3)：369-379.
［28］MA Xiaoli，PARK Yueshan，LU Dehong，et al.Application of sarbox-10 in the differential diagnosis of schwannoma and fibrous meningioma［J］.Journal of diagnostic pathology，2012，19(06)：457-460.［马晓丽，朴月善，卢德宏，等.Sox-10在神经鞘瘤和纤维型脑膜瘤鉴别诊断中的应用［J］.诊断病理学杂志，2012，19(06)：457-460.］
［29］Ng J，Celebre A，Munoz DG，et al.Sox10 is superior to S100 in the diagnosis of meningioma［J］.Appl Immunohistochem Mol Morphol，2015，23(3)：215-219.